JLK gets OK from FDA for ICH diagnosis solution

South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, said on Monday it got 501K approval from the US Food and Drug Admin...
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, said on Monday it got 501K approval from the US Food and Drug Admin...
JLK Inc., South Korea's stroke diagnosis specialist company, announced on Thursday it implemented two artificial intelligence (AI) stroke diagnostic...